CORRIGENDUM.

Abstract

CorrigendumCORRIGENDUMPublished Online:28 May 2020https://doi.org/10.1152/ajpgi.zh3-7794corr.2020Original articleMoreSectionsPDF (18 KB)Download PDF ToolsExport citationAdd to favoritesGet permissionsTrack citations ShareShare onFacebookTwitterLinkedInEmail Su H, Ma C, Liu J, Li N, Gao M, Huang A, Wang X, Huang, W, Huang X. Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma. Am J Physiol Gastrointest Liver Physiol 303: G1245–G1253, 2012. First published October 4, 2012; doi:10.1152/ajpgi.00439.2011.—The supplemental materials were not linked and supplemental Fig. S2 was not cited in the final publication of this article. Supplemental Fig. S2 should be cited in the third sentence of the fourth paragraph of the results as the following:Compared with the control, expression levels of FXR mRNA (Fig. 3A) and FXR protein (Fig. 3, C and E) were dramatically increased in HepG2 cells effectively transduced with LV-FXR-GFP (Supplemental Fig. S2).The online supplemental materials are now fully available.This article has no references to display. Previous Back to Top FiguresReferencesRelatedInformationRelated articlesDownregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma 01 Dec 2012American Journal of Physiology-Gastrointestinal and Liver Physiology More from this issue > Video Abstract Volume 318Issue 6June 2020Pages G1054-G1054 Copyright & PermissionsCopyright © 2020 the American Physiological Societyhttps://doi.org/10.1152/ajpgi.zh3-7794corr.2020PubMed32463320History Published online 28 May 2020 Published in print 1 June 2020 Metrics Downloaded 342 times